Economic Evaluation of New MDR TB Regimens
Conditions: Multi-drug Resistant Tuberculosis; Extensively Drug-Resistant Tuberculosis; Pulmonary Tuberculoses Interventions: Drug: Bedaquiline; Drug: Pretomanid; Drug: Moxifloxacin; Drug: Linezolid; Drug: Clofazimine; Drug: Standard Drugs Sponsors: Medecins Sans Frontieres, Netherlands; London School of Hygiene and Tropical Medicine; Ministry of Health, Republic of Uzbekistan; Ministry of Health, Belarus; TB & HIV Investigative Network (THINK); Liverpool School of Tropical Medicine; Clinical HIV Reserach Unit, Wits Health Consortium; LSHTM Clinical Research Department Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Avelox | Bedaquiline | Belarus Health | Linezolid | Moxifloxacin | Netherlands Health | Research | Tuberculosis | Uzbekistan Health | Zyvox